Taken together, these data demonstrate that GAA-ABE enables efficient editing of pathogenic GAA repeat tracts in FXN alleles of patients with FRDA, significantly increasing FXN transcript levels and suggesting that base editing of GAA repeats can partially rescue molecular hallmarks of FRDA in human cells16,21. The gene discussed is FXN; the disease is Friedreich ataxia.